| BSE: 532321 | Sector: Health care |
| NSE: CADILAHC | ISIN Code: INE010B01027 |
| BSE 00:00 | 26 Feb | 262.95 |
-9.30 (-3.42%) |
OPEN
269.00 |
HIGH
271.30 |
LOW
262.05 |
| NSE 00:00 | 26 Feb | 262.85 |
-9.35 (-3.43%) |
OPEN
270.20 |
HIGH
271.60 |
LOW
262.00 |
| OPEN | 269.00 |
| PREVIOUS CLOSE | 272.25 |
| VOLUME | 33714 |
| 52-Week high | 352.30 |
| 52-Week low | 206.45 |
| P/E | 21.54 |
| Mkt Cap.(Rs cr) | 26,918 |
| Buy Price | 262.95 |
| Buy Qty | 50.00 |
| Sell Price | 268.80 |
| Sell Qty | 10.00 |
9.34 am | 19 Feb 2020 | Business Standard
Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.
7.55 am | 5 Feb 2020 | Business Standard
For ACC, the RSI has signaled a trend reversal while decent volume participation has also been witnessed
3.57 pm | 20 Dec 2019 | Press Trust of India
The United States Food and Drug Administration (USFDA) inspected the company's topical manufacturing facility in Ahmedabad during December 16-20, 2019...
3.54 pm | 12 Dec 2019 | Business Standard
All that happened in markets today.
7.34 pm | 16 Nov 2019 | Press Trust of India
The tablets will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said.
8.52 am | 14 Nov 2019 | Business Standard
Here's a look at the top stocks that may remain in focus today.
2.23 am | 6 Nov 2019 | Business Standard
Krishnanath Munde at Reliance Securities says he does not expect any new drug approval from the facility till it gets regulatory clearance.
1.02 pm | 5 Nov 2019 | Press Trust of India
The approval is for single-dose vials of Cisatracurium Besylate Injection USP with strengths of 10 mg/5 ml and 200 mg/20 ml
9.14 pm | 4 Nov 2019 | Business Standard
The company said the warning letter does not affect the existing business of the company in the US and the existing product supplies from the Moraiya ...
2.40 pm | 24 Oct 2019 | Press Trust of India
The product will be manufactured at Liva Pharma's manufacturing facility at Vadodara
8.04 am | 22 Oct 2019 | Business Standard
Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor
4.31 pm | 1 Oct 2019 | Business Standard
All that happened in markets today.
6.55 am | 23 Sep 2019 | Business Standard
Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor
10.40 pm | 11 Sep 2019 | Business Standard
Restructuring and consumer acquisition to be key drivers of revenue
